The Tuskegee Syphilis Study (1932–1972)

Summary

Between 1932 and 1972, the United States Public Health Service enrolled approximately 600 Black men in Macon County, Alabama, in a study of untreated syphilis: 399 with latent syphilis and 201 controls. The men were never told they had syphilis, were not given penicillin when it became the standard treatment in 1947, and were actively prevented from receiving treatment for the forty years the study ran. A whistleblower’s disclosures reached the Associated Press in July 1972. The resulting public outcry prompted Senate hearings, the termination of the study, and the National Research Act of 1974, the National Commission for the Protection of Human Subjects, and the Belmont Report of 1979. The study is the single most important proximate cause of the modern American framework for ethical oversight of human subjects research.

Background: The PHS Venereal Disease Program and Macon County

The Tuskegee study did not begin as an exercise in malice. It began as a data collection exercise appended to a venereal disease treatment program that had lost its funding. The US Public Health Service had been operating a syphilis treatment program in Macon County, Alabama, beginning in the late 1920s, drawing on funds from the Rosenwald Fund, a Chicago-based philanthropy that had been supporting Black education and health initiatives in the rural South. When that funding was withdrawn after the stock market crash, the PHS faced a specific choice: end the program, or repurpose the population it had assembled for observational research.

In 1932 Macon County, eighty-two percent of residents were Black, median income was one dollar a day, fifteen of the sixteen practicing physicians were white, and syphilis was endemic in a population with almost no access to medical care.(Washington, Harriet A., 2006) The scientific rationale offered at the time drew on a body of medical opinion, itself shaped by racial assumptions with no adequate empirical basis, that syphilis progressed differently in Black and white patients. The specific belief was that syphilis attacked the muscles of Black patients (including the heart) while leaving their less evolved nervous systems relatively unimpaired — in contrast to the neurological ravages it supposedly inflicted on whites.(Washington, Harriet A., 2006) The Oslo study of untreated syphilis in white Norwegian patients (conducted from the 1890s, with retrospective analysis completed in the 1920s) had tracked the natural history of the disease in white Europeans. The Tuskegee study was framed as a parallel investigation of the disease in Black Americans. That the framing assumed a biological difference that had not been demonstrated, and that it selected a population in Macon County precisely because that population had no access to alternative care, were features of the study design from the beginning.(Jonsen, 2000) The PHS’s own 1929 syphilis survey in Macon County had found that 61 percent of true syphilis cases were congenital or nonvenereal, not sexually transmitted — a fact researchers persistently ignored when characterizing Black men as syphilitic through sexual profligacy, revealing how ideological commitments shaped the framing of the data from the outset.(Washington, Harriet A., 2006)

PHS chief Taliaferro Clark saw the county’s high syphilis rate not as requiring treatment but as what Washington calls “an opportunity for experimentation”: Clark proposed that the PHS save the expense of treatment by merely observing the disease’s course in untreated Black men and publishing the data.(Washington, Harriet A., 2006)

The broader cultural backdrop is worth registering. The Sinclair Lewis novel Arrowsmith (1925), published seven years before the Tuskegee study began, depicted a fictional controlled trial of phage treatment for plague on a Caribbean island in which a physician withholds the treatment from part of a plantation population of poor Black workers — “volunteered for that fate by an enlightened planter,” in Lewis’s phrasing — so as not to interrupt the study’s statistical design. The Jackson survey of public health historiography identifies this fictional episode as one that “foreshadows the Tuskegee syphilis trials that would begin within the decade.”(Jackson (ed.), 2011) The ethical logic that made such a trial imaginable in fiction had real analogs in the institutional culture of American public health research.

The Study (1932–1972)

The enrolled men were not told they had syphilis. They were told they were receiving treatment for “bad blood” (a local expression covering a range of ailments) and were offered free medical examinations, free meals on examination days, and, eventually, free burial insurance. The burial insurance was not incidental: the researchers wanted autopsy access, and the promise of burial costs was one of the incentives that maintained enrollment.(Jonsen, 2000) The PHS knew that African Americans feared “free hospital care” because it often meant an autopsy afterward, and designed the burial offer to allay precisely that fear while ensuring the autopsies would proceed.(Washington, Harriet A., 2006)

The study was initially planned for eight months. It ran for forty years.

The PHS sent notices inviting subjects for spinal taps under the guise of treatment, with language declaring “REMEMBER THIS IS YOUR LAST CHANCE FOR SPECIAL FREE TREATMENT” when the procedure was diagnostic, not therapeutic.(Washington, Harriet A., 2006) PHS senior officer O.C. Wenger wrote in 1933, “As I see it, we have no further interest in these patients until they die,” and in 1950 acknowledged that the study had “contributed to their ailments and shortened their lives.”(Washington, Harriet A., 2006) PHS physicians published study results at a 1936 American Medical Association meeting, meaning many white physicians were informed of the study, but not African American physicians, who were largely barred from AMA membership at the time.(Washington, Harriet A., 2006)

In 1934, PHS doctors enlisted local Black physicians not to treat the study subjects; the Black doctors agreed. When the United States entered World War II in 1941, the PHS circulated a list of subjects’ names to draft boards, instructing military physicians not to treat any men who were inducted. Some study participants who made their way to PHS syphilis treatment clinics were physically removed.(Washington, Harriet A., 2006)

Penicillin became the accepted standard of care for syphilis in 1947. The men were not given penicillin. When Surgeon General Thomas Parran was presented with the new cure, he chose to continue the experiment, declaring that the “opportunity” represented by the pool of untreated syphilitic subjects would never come again and “must be exploited.”(Washington, Harriet A., 2006) The study’s value, in the terms the researchers set, lay precisely in the absence of treatment: they were observing untreated disease progression, and treatment would have ended what they were observing. The distinction between the study’s scientific aims and the medical interests of its subjects had been present from the beginning. By 1947 it had become an ongoing decision, repeated year after year, to deny a cure to men who could have been cured.(Montgomery, 2006)

By 1969, physical examinations and autopsies revealed that as many as one hundred of the men had died of syphilis; forty wives were infected and at least nineteen children were born with syphilitic birth defects.(Washington, Harriet A., 2006) That year, a PHS review committee examined the study and reaffirmed its continuation. The committee’s deliberations and the resulting decision to proceed represented institutional knowledge that the men were not receiving treatment and were not being told why.

Montgomery’s framing of the study’s ethical logic is direct: “Patients — or, rather, the men who were its subjects — were denied the newly discovered penicillin so as not to interrupt a study of the natural course of untreated syphilis. It stands as a reminder of the inescapable, necessary difference between science and medicine.”(Montgomery, 2006) The difference Montgomery identifies is not a failure of individual ethics but a structural one: research designed to produce generalizable knowledge about a disease process has interests that are logically distinct from, and in this case directly opposed to, the therapeutic interests of the persons who are its subjects. The Tuskegee study made that conflict visible with unusual clarity.

The Disclosure (1972)

Peter Buxtun, a PHS venereal disease investigator, had raised concerns about the study internally in 1966 and again in 1968, both times without result. In 1972, he provided documentation to Associated Press reporter Jean Heller, whose story ran on July 25 of that year. The story was front-page news across the country.

The public response produced, within months, Senate hearings chaired by Senator Edward Kennedy. The hearings examined not only the Tuskegee study but the broader question of human subjects research oversight in the United States. The study was terminated before the hearings concluded. The subsequent CDC ad hoc panel investigation was narrowly scoped, suffered from destroyed evidence and political infighting, and its chairman found the inquiry deliberately constrained.(Washington, Harriet A., 2006)

The Ethics Inflection: From Tuskegee to Belmont

The Nuremberg Code (1947) had established voluntary informed consent as the foundational requirement for ethical human experimentation. That Code was a response to Nazi medical experiments in the concentration camps; its requirement was not borrowed from existing medical ethics but constructed in response to what happened when that requirement was absent.(Jackson (ed.), 2011) The Tuskegee study had been running for fifteen years before the Nuremberg Code was formulated, and it continued for another twenty-five years after. As Jackson’s overview of the history of medical ethics and law concludes, the study is “only the most prominent example” demonstrating that “Western countries’ researchers routinely failed to meet Nuremberg Code requirements,” and that it raised “the more general question of the effectiveness of ethics codes as long as they are not sufficiently endorsed and enforced by legislation.”(Jackson (ed.), 2011)

The legislative response came from the Kennedy hearings. The National Research Act of 1974 created the National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Jonsen, who was a member of the Commission, describes its mandate: “The task of this Commission, which sat from 1974 to 1978, was to recommend to the federal government regulations that would protect the rights and welfare of human research subjects and to develop the moral principles that should underlie such research.”(Jonsen, 2000) The Commission’s work produced the Belmont Report (1979), which articulated three organizing principles (respect for persons, beneficence, and justice) that became the framework for the Institutional Review Board system and for American research ethics pedagogy through the following decades.(Jonsen, 2000)

The requirement for Institutional Review Boards (IRBs), charged with reviewing and approving all research proposals involving human subjects, was a direct institutional consequence of the recognition that individual researchers and individual research institutions could not be trusted to protect their own subjects without external oversight. The Tuskegee study was not the only case that produced this conclusion, but it was the most politically legible one.

Bill Clinton offered a formal presidential apology to the surviving participants and their families in May 1997.

Reception and Historiography

The study’s historical significance has been approached from two directions in the scholarship. The first is the internal history of American bioethics: how the exposure of Tuskegee reshaped the legislative and regulatory framework for human subjects research. The second is the history of race in American medicine: how the study shaped, and continues to shape, the relationship between Black Americans and medical institutions.

On the first question, Jackson’s survey of contemporary health history identifies the Tuskegee study as a defining episode that “showed the combination of interest in race, research ethics, and sexuality that marked a different outlook in US contemporary history” — distinguishing the American approach to medical ethics historiography from its British counterpart.(Jackson (ed.), 2011) The study had become, by the 1980s and 1990s, a canonical case in bioethics education, functioning as the American equivalent of the Nazi medical experiments for courses in research ethics.

On the second question, the persistence of the study’s effects on Black Americans’ relationship to medical research is a matter of documented sociological observation. Rhodes and colleagues, in their survey of discrimination in medical practice, note that “as a residue of their history with medicine, African-Americans in particular may be suspicious of health care generally and experimentation in particular.”(Rosamond Rhodes, Leslie P. Francis, and Anita Silvers, 2007) The suspicion is not irrational, nor is it reducible to the Tuskegee study alone. It reflects a longer history of differential treatment, exploitation, and exclusion that Tuskegee made dramatically visible. But the study functions as the most legible reference point for that history.

Washington coins the term “iatrophobia” to describe African American fear of medicine as a historically grounded response to centuries of documented abuse, distinguishing it from the “paranoid” label frequently applied to Black research wariness. The term derives from the Greek iatros (healer) and phobia (fear), and Washington’s argument is that this fear is rational in the face of documented institutional behavior, not a pathological suspicion to be overcome.(Washington, Harriet A., 2006) She also documents the active suppression of the history itself: a medical school professor insisted there had been no medical research on African Americans before the Tuskegee study and commanded Washington not to write the book that would demonstrate otherwise.(Washington, Harriet A., 2006)

The early bioethical treatment of Tuskegee concentrated on its most obvious features: vulnerability, coercion, and racial exploitation. What that framing largely set aside, as Rhodes’s analysis notes, was the dimension of transmissibility: the men enrolled had an infectious disease, and the decision not to treat them affected not only themselves but the people with whom they had sexual contact.(Rosamond Rhodes, Leslie P. Francis, and Anita Silvers, 2007) The ethical calculus, in other words, was worse than the most common framing of it suggested: the harm extended beyond the enrolled subjects.

Scholarly Assessment

The Tuskegee study occupies an unusual position in the historiography: the facts of the case, established at the time of the termination and confirmed by subsequent scholarship, are not seriously contested. What remains contested is the interpretive weight to assign to different aspects of the study: whether it was primarily a story of racial exploitation, of institutional cowardice and momentum, of the structural subordination of therapeutic to scientific interests, or of the failure of ethical codes lacking enforcement mechanisms.

Jonsen’s account emphasizes the regulatory consequence: Tuskegee, not the Nuremberg Code, was what finally produced enforceable American law on human subjects research. The Code existed. It was not enforced. The study continued for twenty-five years after the Code was promulgated.(Jonsen, 2000) The lesson that Jackson draws from this juxtaposition is institutional rather than individual: “the more general question of the effectiveness of ethics codes as long as they are not sufficiently endorsed and enforced by legislation” was what the study raised for the field.(Jackson (ed.), 2011)

Montgomery’s analysis locates the study within a broader argument about the structural difference between science and medicine. Scientific research has its own internal logic and its own interests; medicine has a different set of interests, centered on the welfare of the patient in front of the clinician. When those interests are not clearly separated, when the researcher and the clinician are the same person or research protocols are administered through what appears to be a medical relationship, the therapeutic interest can be subordinated to the scientific one without any single actor recognizing themselves as responsible for the subordination.(Montgomery, 2006) The IRB system, the informed consent requirement, and the Belmont principles are all attempts to maintain that separation structurally rather than relying on the individual conscience of individual investigators.

See Also

• belmont-report (in progress — direct institutional consequence of the study’s disclosure)
• nuremberg-code (in progress — the code the study demonstrably failed to enforce)
• holocaust (sister page — parallel case of physician participation in systematic harm)
• medical-ethics (broader history of ethics in Western medicine)
• informed-consent (the principle the study violated and the Belmont Report systematized)

Sources

• Jonsen, Albert R. (2000). A Short History of Medical Ethics. Oxford University Press. (source_id: jonsen-short-history-medical-2000)
• Jackson, Mark (ed.). (2011). The Oxford Handbook of the History of Medicine. Oxford University Press. (source_id: jackson-oxfordhandbook-2011)
• Montgomery, Kathryn. (2006). How Doctors Think: Clinical Judgment and the Practice of Medicine. Oxford University Press. (source_id: montgomery-how-doctors-think-2006)
• Rhodes, Rosamond, Margaret P. Battin, and Anita Silvers (eds.). (2012). Medicine and Social Justice: Essays on the Distribution of Health Care. Oxford University Press. (source_id: rhodes-medicine-social-justice)
• Washington, Harriet A. (2006). Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present. Doubleday. (source_id: washington-medicalapartheid-2006)

Editorial Notes

Gaps the encyclopaedia compiler flagged for future evidence work.